Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Hydroxyethyl starch 130/0.38-0.45 versus crystalloid or albumin in patients with sepsis: systematic review with meta-analysis and trial sequential analysis

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Prospective risk of stillbirth and neonatal complications in twin pregnancies: systematic review and meta-analysis

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Re: Restoring Study 329: efficacy and harms of paroxetine and imipramine in treatment of major depression in adolescence

    Research output: Contribution to journalComment/debateResearchpeer-review

  3. "Adaptive pathways" to drug authorisation: adapting to industry?

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Antidepressants are addictive and increase the risk of relapse

    Research output: Contribution to journalLetterResearchpeer-review

  5. Author's reply to Dubicka and colleagues and Stone

    Research output: Contribution to journalComment/debateResearchpeer-review

  1. Lactate versus acetate buffered intravenous crystalloid solutions: a scoping review

    Research output: Contribution to journalReviewResearchpeer-review

  2. Evaluating Non-Statistically Significant Results From Trials in Practice-Reply

    Research output: Contribution to journalComment/debateResearchpeer-review

View graph of relations
To assess the effects of fluid therapy with hydroxyethyl starch 130/0.38-0.45 versus crystalloid or albumin on mortality, kidney injury, bleeding, and serious adverse events in patients with sepsis.
Original languageEnglish
JournalB M J
Volume346
Pages (from-to)f839
ISSN0959-8146
DOIs
Publication statusPublished - 2013

    Research areas

  • Fluid Therapy, Hetastarch, Humans, Isotonic Solutions, Sepsis, Serum Albumin

ID: 38373576